Wei-en Wang

Research Assistant Professor University of Florida

Gainesville FL

Wei-en Wang researches brain imaging (EEG, MRI, PET) and its applications in cognitive and motor impairments.

Contact

University of Florida
View more experts managed by University of Florida

View all Experts

Biography

Wei-en Wang's work is focused on identifying and validating neuroimaging biomarkers that improve early diagnosis and predict disease progression in people with neurodegenerative diseases such as dementia and parkinsonism. She has developed imaging pipelines for various imaging modalities, including EEG, structural MRI, diffusion MRI, PET, and CT. The validation of innovative neuroimaging biomarkers has produced a series of publications in leading journals and presentations at international conferences on mild cognitive impairment, Alzheimer’s disease (AD), Lewy body disease, and chronic pain in human clinical populations.

Areas of Expertise

Cortical Oscillations

Alzheimer's Disease and Related Dementias

Neuroscience and the Brain

Neuroscience

Structural and Functional Imaging

Articles

Longitudinal Free-Water Changes in Dementia with Lewy Bodies

Movement Disorders

Shannon Y. Chiu, et. al

2024-03-13

Diffusion-weighted magnetic resonance imaging (dMRI) examines tissue microstructure integrity in vivo. Prior dementia with Lewy bodies (DLB) diffusion tensor imaging studies yielded mixed results.

Diffusion MRI relates to plasma Aβ42/40 in PET negative participants without dementia

Alzheimer's & Dementia

Jesse C. DeSimone, et. al

2024-03-05

Magnetic resonance imaging (MRI) biomarkers are needed for indexing early biological stages of Alzheimer's disease (AD), such as plasma amyloid-β (Aβ42/40) positivity in Aβ positron emission tomography (PET) negative individuals.

Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adults

Alzheimer's & Dementia

Breton M. Asken, et. al

2023-09-06

We evaluated associations between plasma biomarkers commonly studied in Alzheimer's (p-tau181, GFAP, and NfL), clinical diagnosis (clinically normal, amnestic MCI, amnestic dementia, or non-amnestic MCI/dementia), and Aβ-PET in Hispanic and non-Hispanic older adults. Hispanics were predominantly of Cuban or South American ancestry.